caffeine has been researched along with Anxiety Disorders in 53 studies
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects on measures of anxiety from two doses of oral caffeine (250 and 500 mg) and placebo were compared in 12 patients with generalized anxiety disorder (GAD), 12 patients with panic disorder, and 12 normal subjects." | 9.07 | Anxiogenic effects of caffeine in patients with anxiety disorders. ( Bruce, M; Lader, M; Scott, N; Shine, P, 1992) |
| "The behavioral and neuroendocrine effects of meta-chlorophenylpiperazine (m-CPP), a serotonergic agonist, were compared with the effects of caffeine, an adenosine antagonist, in panic disorder patients." | 9.07 | Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. ( Geraci, MF; Klein, E; Murphy, DL; Uhde, TW; Zohar, J, 1991) |
| "This systematic review aimed to examine the results of studies that have investigated the induction of panic attacks and/or the anxiogenic effect of the caffeine challenge test in patients with panic disorder." | 8.87 | Caffeine challenge test and panic disorder: a systematic literature review. ( Nardi, AE; Rocha Araujo, DM; Vilarim, MM, 2011) |
| "To create a match/mismatch of expected and experienced arousal, high and low anxiety sensitive participants received caffeine vs." | 7.81 | Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge. ( Benke, C; Blumenthal, TD; Hamm, AO; Modeß, C; Pané-Farré, CA, 2015) |
| "Caffeine toxicity remains a rarely reported condition, which may mimic anxiety disorders." | 7.67 | Caffeine abstention in the management of anxiety disorders. ( Bruce, MS; Lader, M, 1989) |
| "The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder." | 6.15 | Increased anxiogenic effects of caffeine in panic disorders. ( Charney, DS; Heninger, GR; Jatlow, PI, 1985) |
| "Caffeine is a central nervous system stimulant and acts in the brain through adenosine receptors, influencing attention, alertness, and anxiety." | 5.72 | Caffeine-related genes influence anxiety disorders in children and adults with ADHD. ( Bandeira, CE; Bau, CHD; Contini, V; da Silva, BS; Dresch, F; Fraporti, TT; Genro, JP; Grevet, EH; Hutz, MH; Martins-Silva, T; Rohde, LA; Rovaris, DL; Tovo-Rodrigues, L, 2022) |
| "The effects on measures of anxiety from two doses of oral caffeine (250 and 500 mg) and placebo were compared in 12 patients with generalized anxiety disorder (GAD), 12 patients with panic disorder, and 12 normal subjects." | 5.07 | Anxiogenic effects of caffeine in patients with anxiety disorders. ( Bruce, M; Lader, M; Scott, N; Shine, P, 1992) |
| "The behavioral and neuroendocrine effects of meta-chlorophenylpiperazine (m-CPP), a serotonergic agonist, were compared with the effects of caffeine, an adenosine antagonist, in panic disorder patients." | 5.07 | Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. ( Geraci, MF; Klein, E; Murphy, DL; Uhde, TW; Zohar, J, 1991) |
| "This systematic review aimed to examine the results of studies that have investigated the induction of panic attacks and/or the anxiogenic effect of the caffeine challenge test in patients with panic disorder." | 4.87 | Caffeine challenge test and panic disorder: a systematic literature review. ( Nardi, AE; Rocha Araujo, DM; Vilarim, MM, 2011) |
| "To create a match/mismatch of expected and experienced arousal, high and low anxiety sensitive participants received caffeine vs." | 3.81 | Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge. ( Benke, C; Blumenthal, TD; Hamm, AO; Modeß, C; Pané-Farré, CA, 2015) |
| "Caffeine toxicity remains a rarely reported condition, which may mimic anxiety disorders." | 3.67 | Caffeine abstention in the management of anxiety disorders. ( Bruce, MS; Lader, M, 1989) |
| "Caffeine increases anxiety in people with anxiety disorders." | 3.67 | Anxiogenic effects of caffeine on panic and depressed patients. ( Cameron, OG; Flegel, P; Greden, JF; Lee, MA, 1988) |
| "Generalized anxiety disorder and major depressive disorder often benefit from medication and psychotherapy." | 1.91 | Relationship between Baseline Physical Activity and Generalized Anxiety Disorder and Major Depressive Disorder Treatment Outcomes. ( Benitah Bulbarelli, EM; Chauhan, M; Clapp, AD; Ismaeel, O; Niazi, SK; Nishi, LM; Pujalte, GGA; Shahsamand, A; Yazeji, J, 2023) |
| "Caffeine is a central nervous system stimulant and acts in the brain through adenosine receptors, influencing attention, alertness, and anxiety." | 1.72 | Caffeine-related genes influence anxiety disorders in children and adults with ADHD. ( Bandeira, CE; Bau, CHD; Contini, V; da Silva, BS; Dresch, F; Fraporti, TT; Genro, JP; Grevet, EH; Hutz, MH; Martins-Silva, T; Rohde, LA; Rovaris, DL; Tovo-Rodrigues, L, 2022) |
| "Caffeine-treated adolescent male rats were exposed to caffeine (0." | 1.56 | Pharmacological depletion of serotonin and norepinephrine with para-chlorophenylalanine and alpha-methyl-p-tyrosine reverses the antidepressant-like effects of adolescent caffeine exposure in the male rat. ( Abdulzahir, A; Hwang, K; Sanford, J; Turgeon, SM, 2020) |
| "GAD, phobias, and MDD shared genetic factors with caffeine use, with genetic correlations estimated to be 0." | 1.38 | Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects. ( Bergin, JE; Kendler, KS, 2012) |
| "Thirty youth with major depressive disorder (MDD) and 23 control youth reported on caffeine use, sleep, and affect in their natural environment using ecological momentary assessment at baseline and over 8 weeks, while MDD youth received treatment." | 1.35 | Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls. ( Axelson, DA; Birmaher, B; Dahl, RE; Forbes, EE; Ryan, ND; Semel, M; Silk, JS; Whalen, DJ, 2008) |
| "Caffeine is a widely ingested and generally beneficial drug." | 1.28 | Caffeine and caffeinism. ( Mackay, DC; Rollins, JW, 1989) |
| "The association of three subtypes of insomnia with psychic and functional syndromes, and the course of insomnia over 7 years were examined in a Swiss cohort of young adults interviewed three times." | 1.28 | The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. ( Angst, J; Vollrath, M; Wicki, W, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (50.94) | 18.7374 |
| 1990's | 9 (16.98) | 18.2507 |
| 2000's | 4 (7.55) | 29.6817 |
| 2010's | 7 (13.21) | 24.3611 |
| 2020's | 6 (11.32) | 2.80 |
| Authors | Studies |
|---|---|
| Fraporti, TT | 1 |
| Bandeira, CE | 1 |
| Tovo-Rodrigues, L | 1 |
| Martins-Silva, T | 1 |
| Hutz, MH | 1 |
| Rohde, LA | 1 |
| Bau, CHD | 1 |
| Grevet, EH | 1 |
| da Silva, BS | 1 |
| Rovaris, DL | 1 |
| Dresch, F | 1 |
| Contini, V | 1 |
| Genro, JP | 1 |
| Paz-Graniel, I | 1 |
| Kose, J | 1 |
| Babio, N | 1 |
| Hercberg, S | 1 |
| Galan, P | 1 |
| Touvier, M | 1 |
| Salas-Salvadó, J | 1 |
| Andreeva, VA | 1 |
| Adcock, S | 1 |
| Lang, B | 1 |
| Atila, O | 1 |
| Deniz, E | 1 |
| Ari, A | 1 |
| Sengur, A | 1 |
| Chakraborty, S | 1 |
| Barua, PD | 1 |
| Acharya, UR | 1 |
| Clapp, AD | 1 |
| Pujalte, GGA | 1 |
| Nishi, LM | 1 |
| Benitah Bulbarelli, EM | 1 |
| Yazeji, J | 1 |
| Shahsamand, A | 1 |
| Niazi, SK | 1 |
| Ismaeel, O | 1 |
| Chauhan, M | 1 |
| Turgeon, SM | 2 |
| Abdulzahir, A | 1 |
| Hwang, K | 1 |
| Sanford, J | 1 |
| Nelson, ST | 1 |
| Hsiao, L | 1 |
| Benke, C | 1 |
| Blumenthal, TD | 1 |
| Modeß, C | 1 |
| Hamm, AO | 1 |
| Pané-Farré, CA | 1 |
| Richards, G | 1 |
| Smith, A | 1 |
| Hofmann, SG | 1 |
| Smits, JA | 1 |
| Asnaani, A | 1 |
| Gutner, CA | 1 |
| Otto, MW | 1 |
| Vilarim, MM | 1 |
| Rocha Araujo, DM | 1 |
| Nardi, AE | 1 |
| Bergin, JE | 1 |
| Kendler, KS | 1 |
| Altmaier, E | 1 |
| Emeny, RT | 1 |
| Krumsiek, J | 1 |
| Lacruz, ME | 1 |
| Lukaschek, K | 1 |
| Häfner, S | 1 |
| Kastenmüller, G | 1 |
| Römisch-Margl, W | 1 |
| Prehn, C | 1 |
| Mohney, RP | 1 |
| Evans, AM | 1 |
| Milburn, MV | 1 |
| Illig, T | 1 |
| Adamski, J | 1 |
| Theis, F | 1 |
| Suhre, K | 1 |
| Ladwig, KH | 1 |
| LUNDERQUIST, B | 1 |
| Ströhle, A | 1 |
| Cooper, M | 1 |
| Safran, M | 1 |
| Eberhardt, M | 1 |
| Whalen, DJ | 1 |
| Silk, JS | 1 |
| Semel, M | 1 |
| Forbes, EE | 1 |
| Ryan, ND | 1 |
| Axelson, DA | 1 |
| Birmaher, B | 1 |
| Dahl, RE | 1 |
| Childs, E | 1 |
| Hohoff, C | 1 |
| Deckert, J | 1 |
| Xu, K | 1 |
| Badner, J | 1 |
| de Wit, H | 1 |
| Skolnick, P | 1 |
| Paul, SM | 1 |
| Smith, JM | 1 |
| Pearson, S | 1 |
| Marks, V | 1 |
| Snyder, SH | 1 |
| Sklar, P | 1 |
| James, JE | 1 |
| Stirling, KP | 1 |
| Boulenger, JP | 2 |
| Uhde, TW | 6 |
| Wolff, EA | 1 |
| Post, RM | 1 |
| Koenigsberg, HW | 1 |
| Pollak, CP | 1 |
| Fine, J | 1 |
| Mayo, KM | 1 |
| Falkowski, W | 1 |
| Jones, CA | 1 |
| Lande, RG | 1 |
| Labbate, LA | 1 |
| Furlong, FW | 1 |
| Hirvonen, L | 1 |
| Bruce, M | 1 |
| Scott, N | 1 |
| Shine, P | 1 |
| Lader, M | 2 |
| Klein, E | 1 |
| Zohar, J | 1 |
| Geraci, MF | 1 |
| Murphy, DL | 1 |
| Cameron, OG | 3 |
| Modell, JG | 1 |
| Hariharan, M | 1 |
| Bruce, MS | 2 |
| Mathew, RJ | 1 |
| Wilson, WH | 1 |
| Mackay, DC | 1 |
| Rollins, JW | 1 |
| DeMet, E | 1 |
| Stein, MK | 1 |
| Tran, C | 1 |
| Chicz-DeMet, A | 1 |
| Sangdahl, C | 1 |
| Nelson, J | 1 |
| Mellman, TA | 1 |
| Vollrath, M | 1 |
| Wicki, W | 1 |
| Angst, J | 1 |
| Breier, A | 2 |
| Charney, DS | 3 |
| Heninger, GR | 3 |
| Migneco, G | 1 |
| Mascarella, A | 1 |
| Tripi, S | 1 |
| La Cascia, C | 1 |
| Navetta, A | 1 |
| Jatlow, PI | 1 |
| Rainey, JM | 1 |
| Nesse, RM | 1 |
| Roy-Byrne, PP | 1 |
| Lee, MA | 2 |
| Flegel, P | 1 |
| Greden, JF | 3 |
| Shear, MK | 1 |
| Rosenbaum, JF | 1 |
| Vittone, BJ | 1 |
| Cardon, PV | 1 |
| Weiss, JL | 1 |
| Mueller, PS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association Between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects With Panic Disorder and Healthy Controls[NCT00083265] | 117 participants (Actual) | Observational | 2004-05-13 | Completed | |||
| The Impact of Caffeine on Cognition in Schizophrenia[NCT02832401] | 24 participants (Actual) | Interventional | 2016-09-02 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for caffeine and Anxiety Disorders
| Article | Year |
|---|---|
Cognitive enhancers for anxiety disorders.
Topics: Animals; Anxiety Disorders; Benzhydryl Compounds; Caffeine; Clinical Trials as Topic; Cognitive Beha | 2011 |
Caffeine challenge test and panic disorder: a systematic literature review.
Topics: Anxiety Disorders; Caffeine; Central Nervous System Stimulants; Diagnostic Techniques, Neurological; | 2011 |
[Experimental provocation of panic attacks as a human experimental model for anxiety].
Topics: Anxiety Disorders; Atrial Natriuretic Factor; Bicarbonates; Caffeine; Disease Models, Animal; Lactat | 2003 |
The mechanism(s) of action of the benzodiazepines.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Caffeine; Carbolines; C | 1981 |
Caffeine: a survey of some of the known and suspected deleterious effects of habitual use.
Topics: Abnormalities, Drug-Induced; Anxiety Disorders; Behavior Therapy; Caffeine; Coffee; Diagnosis, Diffe | 1983 |
Possible psychiatric significance of excessive coffee consumption.
Topics: Adult; Anxiety Disorders; Blood Pressure; Caffeine; Canada; Cardiovascular System; Cerebrovascular C | 1975 |
[Coffee and health].
Topics: Anxiety Disorders; Blood Pressure; Caffeine; Central Nervous System; Coffee; Diuresis; Humans; Neopl | 1992 |
The diagnostic validity of anxiety disorders and their relationship to depressive illness.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Caffeine; Clonidine; | 1985 |
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; | 1985 |
Psychobiology of anxiety and anxiety disorders.
Topics: Animals; Anxiety; Anxiety Disorders; Blood Platelets; Caffeine; Carbolines; Carbon Dioxide; Cats; Di | 1985 |
Exogenous factors in panic disorder: clinical and research implications.
Topics: Anxiety Disorders; Caffeine; Cocaine; Diet; Ethanol; Fear; Humans; Life Change Events; Marijuana Abu | 1988 |
Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data.
Topics: Anxiety Disorders; Arousal; Caffeine; Calmodulin; Carbon Monoxide; Fear; Humans; Imagination; Isopro | 1986 |
Differential diagnosis and treatment of panic disorder: a medical model perspective.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Caffeine; | 1985 |
5 trials available for caffeine and Anxiety Disorders
| Article | Year |
|---|---|
Caffeine: use and effects in long-stay psychiatric patients.
Topics: Adult; Aged; Anxiety Disorders; Caffeine; Depressive Disorder; Dose-Response Relationship, Drug; Dou | 1993 |
Caffeine use and plasma concentrations in psychiatric outpatients.
Topics: Adjustment Disorders; Adult; Age Factors; Alcohol Drinking; Analysis of Variance; Anxiety Disorders; | 1998 |
Anxiogenic effects of caffeine in patients with anxiety disorders.
Topics: Alpha Rhythm; Anxiety Disorders; Blood Pressure; Caffeine; Diagnosis, Differential; Double-Blind Met | 1992 |
Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
Topics: Adult; Anxiety Disorders; Arousal; Brain; Caffeine; Double-Blind Method; Female; Humans; Hydrocortis | 1991 |
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; | 1985 |
36 other studies available for caffeine and Anxiety Disorders
| Article | Year |
|---|---|
Caffeine-related genes influence anxiety disorders in children and adults with ADHD.
Topics: Adult; Anxiety; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Caffeine; Central | 2022 |
Caffeine Intake and Its Sex-Specific Association with General Anxiety: A Cross-Sectional Analysis among General Population Adults.
Topics: Adult; Aged; Anxiety; Anxiety Disorders; Caffeine; Cross-Sectional Studies; Female; Humans; Logistic | 2022 |
Caffeine Motives and Expectancies for Individuals with High Anxiety Sensitivity.
Topics: Adaptation, Psychological; Alcohol Drinking; Anxiety; Anxiety Disorders; Caffeine; Fear; Humans; Mot | 2023 |
LSGP-USFNet: Automated Attention Deficit Hyperactivity Disorder Detection Using Locations of Sophie Germain's Primes on Ulam's Spiral-Based Features with Electroencephalogram Signals.
Topics: Algorithms; Anxiety; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Caffeine; Chi | 2023 |
Relationship between Baseline Physical Activity and Generalized Anxiety Disorder and Major Depressive Disorder Treatment Outcomes.
Topics: Adult; Anxiety; Anxiety Disorders; Caffeine; Depression; Depressive Disorder, Major; Humans; Retrosp | 2023 |
Pharmacological depletion of serotonin and norepinephrine with para-chlorophenylalanine and alpha-methyl-p-tyrosine reverses the antidepressant-like effects of adolescent caffeine exposure in the male rat.
Topics: Age Factors; alpha-Methyltyrosine; Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Behav | 2020 |
Sex and housing conditions modify the effects of adolescent caffeine exposure on anxiety-like and depressive-like behavior in the rat.
Topics: Age Factors; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Caffeine; Depression; Depressive | 2019 |
Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge.
Topics: Adult; Anticipation, Psychological; Anxiety; Anxiety Disorders; Arousal; Attention; Autonomic Nervou | 2015 |
Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children.
Topics: Adolescent; Anxiety; Anxiety Disorders; Caffeine; Carbonated Beverages; Child; Coffee; Cross-Section | 2015 |
Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects.
Topics: Adult; Anorexia Nervosa; Anxiety Disorders; Bulimia; Caffeine; Depressive Disorder, Major; Diseases | 2012 |
Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of Type D personality.
Topics: Adult; Aged; Androsterone; Anxiety Disorders; Caffeine; Case-Control Studies; Cross-Sectional Studie | 2013 |
[TRIAL OF SINEDYL WITH NEUROTIC PATIENTS IN GENERAL PRACTICE].
Topics: Anxiety; Anxiety Disorders; Atropa belladonna; Biomedical Research; Caffeine; General Practice; Huma | 1964 |
Caffeine consumption among adults on benzodiazepine therapy: United States 1988-1994.
Topics: Aged; Anxiety Disorders; Arousal; Benzodiazepines; Caffeine; Dose-Response Relationship, Drug; Drug | 2004 |
Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls.
Topics: Adolescent; Affect; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Beverages; Caf | 2008 |
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.
Topics: Adenosine; Adolescent; Adult; Anxiety Disorders; Brain; Brain Chemistry; Caffeine; DNA Mutational An | 2008 |
Plasma caffeine concentration in outpatients.
Topics: Ambulatory Care; Anxiety Disorders; Caffeine; Female; Humans; Male; Syndrome | 1982 |
Behavioral and molecular actions of caffeine: focus on adenosine.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Anxiety Disorders; Behavior; Caffeine; Child; Cycli | 1984 |
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.
Topics: Adult; Anxiety Disorders; Arousal; Caffeine; Coffee; Depressive Disorder; Fear; Female; Humans; Male | 1984 |
Caffeine consumption and anxiety: preliminary results of a survey comparing patients with anxiety disorders and normal controls.
Topics: Adult; Anxiety Disorders; Caffeine; Female; Humans; Male | 1982 |
Olfactory hallucinations after the infusion of caffeine during sleep.
Topics: Adult; Anxiety Disorders; Caffeine; Female; Hallucinations; Humans; Infusions, Intravenous; Male; Mi | 1993 |
Editorial: Anxiety symptoms and coffee drinking.
Topics: Anxiety Disorders; Caffeine; Coffee; Headache; Humans | 1975 |
Caffeine and human cerebral blood flow: a positron emission tomography study.
Topics: Administration, Oral; Adult; Anxiety Disorders; Blood Flow Velocity; Blood Pressure; Brain; Caffeine | 1990 |
The anxiogenic effects of caffeine.
Topics: Adult; Anxiety Disorders; Caffeine; Diet; Female; Humans; Panic; Substance Withdrawal Syndrome | 1990 |
Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders.
Topics: Adult; Anxiety Disorders; Arousal; Caffeine; Cerebrovascular Circulation; Dose-Response Relationship | 1990 |
Caffeine and caffeinism.
Topics: Adult; Anxiety Disorders; Caffeine; Humans; Male; Military Personnel; Mood Disorders; Naval Medicine | 1989 |
Caffeine taste test for panic disorder: adenosine receptor supersensitivity.
Topics: Adult; Anxiety Disorders; Arousal; Brain; Caffeine; Fear; Female; Humans; Male; Panic; Quinine; Rece | 1989 |
Caffeine abstention in the management of anxiety disorders.
Topics: Adult; Anxiety Disorders; Arousal; Caffeine; Dose-Response Relationship, Drug; Female; Follow-Up Stu | 1989 |
Sleep panic attacks: new clinical findings and theoretical implications.
Topics: Adult; Anxiety Disorders; Caffeine; Fear; Female; Humans; Male; Middle Aged; Panic; Sleep Initiation | 1989 |
The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia.
Topics: Adult; Alcohol Drinking; Anxiety Disorders; Caffeine; Cohort Studies; Conflict, Psychological; Depre | 1989 |
[Cytolytic episodes during cirrhosis].
Topics: Antipyrine; Anxiety Disorders; Barbiturates; Caffeine; Cholestasis; Drug Therapy, Combination; Femal | 1986 |
Anxiogenic effects of caffeine on panic and depressed patients.
Topics: Adult; Anxiety Disorders; Bipolar Disorder; Caffeine; Coffee; Depressive Disorder; Drinking; Fear; F | 1988 |
Cocaine and panic disorder.
Topics: Adult; Anxiety Disorders; Caffeine; Cocaine; Coffee; Fear; Humans; Male; Panic; Substance-Related Di | 1986 |
Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
Topics: Adult; Agoraphobia; Alcoholism; Anxiety Disorders; Caffeine; Chronic Disease; Depressive Disorder; D | 1986 |
Anxiety and caffeine consumption in people with anxiety disorders.
Topics: Adult; Anxiety Disorders; Caffeine; Dose-Response Relationship, Drug; Female; Humans; Male; Psycholo | 1985 |
Anxiety or caffeinism: a diagnostic dilemma.
Topics: Adult; Anxiety Disorders; Cacao; Caffeine; Carbonated Beverages; Coffee; Diagnosis, Differential; Do | 1974 |
Effects of small intravenous doses of epinephrine on serum insulin, glucose tolerance and serum free fatty acids.
Topics: Adolescent; Adult; Anxiety Disorders; Biological Assay; Blood Glucose; Caffeine; Epinephrine; Fatty | 1974 |